Search Results - "Berger, William E"

Refine Results
  1. 1

    Intranasal spray medications for maintenance therapy of allergic rhinitis by Berger, William E, Meltzer, Eli O

    Published in American journal of rhinology & allergy (01-07-2015)
    “…Intranasal sprays are recommended as targeted therapy for allergic rhinitis (AR) by providing direct delivery of medication to the nasal mucosa, reducing the…”
    Get full text
    Journal Article
  2. 2

    Efficacy Analysis of MP-AzeFlu Compared with Fluticasone Propionate Nasal Spray in Children 6 through 11 Years of Age with Allergic Rhinitis by Sher, Ellen R., MD, FAAAAI, Berger, William E., MD, MBA

    Published in Journal of allergy and clinical immunology (01-02-2017)
    “…Rationale MP-AzeFlu (Dymista®) is a novel intranasal formulation of azelastine hydrochloride (AZE) and fluticasone propionate (FP) for treatment of allergic…”
    Get full text
    Journal Article
  3. 3

    A double-blind, placebo-controlled trial of the efficacy and safety of two doses of azelastine hydrochloride in perennial allergic rhinitis by Bousquet, Jean, Klimek, Ludger, Kuhl, Hans-Christian, Nguyen, Duc Tung, Ramalingam, Rajesh Kumar, Canonica, G. W., Berger, William E.

    Published in Frontiers in allergy (18-10-2023)
    “…Background Azelastine hydrochloride (AZE) is a selective, non-sedating H1 antagonist with anti-inflammatory and mast cell stabilizing properties, which can be…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Efficacy and safety of beclomethasone dipropionate nasal aerosol in children with perennial allergic rhinitis by Berger, William E., MD, Jacobs, Robert L., MD, Amar, Niran J., MD, Tantry, Sudeesh K., PhD, Li, Jiang, MS, Small, Calvin J., MD, MS

    Published in Annals of allergy, asthma, & immunology (01-08-2015)
    “…Abstract Background Beclomethasone dipropionate (BDP) nasal aerosol (non-aqueous) is approved for management of seasonal and perennial allergic rhinitis (PAR)…”
    Get full text
    Journal Article
  6. 6

    Efficacy of MP-Azeflu in the Treatment of Postnasal Drip and Rhinorrhea in Patients with Seasonal Allergic Rhinitis (SAR) by Sher, Ellen R., MD FAAAAI, Gawchik, Sandra M., DO, FAAAAI, Berger, William E., MD MBA FAAAAI, Meltzer, Eli O., MD FAAAAI

    Published in Journal of allergy and clinical immunology (01-02-2016)
    “…Rationale The objective of this analysis was to evaluate MP-AzeFlu (Dymista), an intranasal formulation of azelastine HCL (AZE) and fluticasone propionate (FP)…”
    Get full text
    Journal Article
  7. 7

    The use of inhaled formoterol in the treatment of asthma by Berger, William E

    Published in Annals of allergy, asthma, & immunology (01-07-2006)
    “…To discuss the clinical efficacy and safety of formoterol when used to relieve symptoms of asthma and prevent exercise-induced bronchoconstriction (EIB). A…”
    Get more information
    Journal Article
  8. 8
  9. 9
  10. 10

    Quantification of the Distribution of Azelastine HCl/Fluticasone Propionate Nasal Spray in an Anatomical Model of the Human Nasal Cavity by D'Addio, Alexander, PhD, Ruiz, Nancy, MD, Mayer, Michael, PhD, Berger, William E., MD, MBA, FAAAAI, Meltzer, Eli O., MD, FAAAAI

    Published in Journal of allergy and clinical immunology (01-02-2015)
    “…Rationale In vitro evaluations using an anatomical model of the human nasal cavity quantified the distribution of azelastine HCl (AZ) and fluticasone…”
    Get full text
    Journal Article
  11. 11

    The efficacy of intranasal antihistamines in the treatment of allergic rhinitis by Kaliner, Michael A., MD, Berger, William E., MD, Ratner, Paul H., MD, Siegel, Charles J., MD

    Published in Annals of allergy, asthma, & immunology (01-02-2011)
    “…Objectives To discuss the new use of intranasal antihistamines as first-line therapies, compare and contrast this class of medication with the traditionally…”
    Get full text
    Journal Article
  12. 12

    Intranasal corticosteroids: the development of a drug delivery device for fluticasone furoate as a potential step toward improved compliance by Berger, William E, Godfrey, James W, Slater, Anna L

    Published in Expert opinion on drug delivery (01-11-2007)
    “…Devices for the aqueous delivery of intranasal corticosteroids to patients with allergic rhinitis have been available since 1984, so there is a need for new…”
    Get more information
    Journal Article
  13. 13

    The safety and efficacy of desloratadine for the management of allergic disease by BERGER, William E

    Published in Drug safety (01-01-2005)
    “…Allergic disease is an increasing problem worldwide. Allergic rhinitis, an inflammatory response to an allergen, affects an estimated 20-40 million people in…”
    Get full text
    Journal Article
  14. 14

    New approaches to managing asthma: a US perspective by Berger, William E

    Published in Therapeutics and clinical risk management (01-04-2008)
    “…Despite remarkable advances in diagnosis and long-term management, asthma remains a serious public health concern. Newly updated expert guidelines emphasize…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Judicious Antibiotic Use and Intranasal Corticosteroids in Acute Rhinosinusitis by Small, Catherine Butkus, MD, Bachert, Claus, MD, PhD, Lund, Valerie J., MS, FRCS, FRCSEd, Moscatello, Augustine, MD, Nayak, Anjuli S., MD, Berger, William E., MD, MBA

    Published in The American journal of medicine (01-04-2007)
    “…Abstract Most patients with symptoms of acute rhinosinusitis are treated with antibiotics. However, many cases of rhinosinusitis are secondary to viral…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Diagnosis and management of allergic conjunctivitis in pediatric patients by Berger, William E, Granet, David B, Kabat, Alan G

    Published in Allergy and asthma proceedings (01-01-2017)
    “…Allergic conjunctivitis (AC), although one of the most common ocular disorders in pediatric patients, is frequently overlooked, misdiagnosed, and undertreated…”
    Get more information
    Journal Article
  20. 20